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Abstract   
Background: This study aims to evaluate the effectiveness of home isolation and medical follow-up by analyzing data 
collected over the phone from isolated individuals. 
Methods: A cross-sectional phone-based survey designed to evaluate the home isolated COVID-19 suspected 
patients at the Şişli Hamidiye Etfal Family Health Center in Istanbul city between 16th  March  5th May 2020.  A semi-
structured questionnaire and the universal sampling technique were recruited to collect data about the socio-
demographic and the COVID-19 related laboratory and clinical findings. The SPSS for Windows program was used to 
perform a univariate and bivariate statistical analysis. The Statistical alpha significance level was accepted at less than 
0.05. 
Results: A total of 463 confirmed, probable, or suspected cases of COVID-19 took part in this study with a mean age 
of 35.38 ∓17.1 (range: 0-86 years). Tow-third 310 (67.0%) underwent the PCR tests, and 67 (21.6%) confirmed 
positive results. Moreover, one-third (159, 34.3%) exposed to CT scans; however, 51(32.3%) were compatible with 
COVID-19. The median age of individuals with PCR positive was 38 years. More than half (40, 59.7%) were males, 
compared to 27 (40.3%) were females. There was no significant relationship between PCR positivity and pandemic 
period, age, or gender (P = 0.149; P = 0.545; P = 0.285), respectively. Although older individuals had a higher rate of 
CT scan compatible with COVID-19, the relation between increased age and COVID-19 compatible CT was found not 
to be statistically significant (P = 0.053). Moreover, there was  significant relationship between CT scan positivity and 
coughing, the tobacco smoking and diabetes (P = 0.003; P = 0.032; P = 0.016),  respectively. 
Conclusion: Combining PCR, symptoms, and CT together doubles the likelihood of a correct diagnosis. Quarantined 
patients must be regularly monitored. 
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Background  
A new type of coronavirus, SARS-COV-2, was first isolated 
during an investigation into an outbreak of pneumonia cases of 
unknown etiology that occurred on 31st December 2019 in 
Wuhan, China [1]. The World Health Organization (WHO) 
named the disease caused by this virus COVID-19 on 11th 
February 2020 [2]. The world was not ready to face a global 
crisis in a unified manner. The virus spread rapidly in most 
countries of the world [3]. The WHO officially declared 
COVID-19 as a pandemic on the 11th of March 2020, the day 
when the first positive case was detected in Turkey [4]. Turkey 
was among the first countries that start preparing and planning 
early to control the spread of the virus and its impact. Turkey 
has adopted the filiation technique to prevent the spread of 
Coronavirus disease by cutting the chain of transmission by 
systematically tracking and isolating vulnerable individuals who 
have been in contact with any confirmed cases. The peak level 
of COVID-19 in Turkey was reached 25 days after the first 
fatality was recorded on 11th April 2020 [5]. According to the 
'COVID-19 (SARS-COV-2) Infection Guide' published by the 
Scientific Committee in the Ministry of Health in Turkey, the 
following groups were treated as definite cases and isolated at 
home for 14 days [6]; people who came from abroad, those who 
had come into contact with confirmed cases and people with a 
confirmed diagnosis. This process was controlled by phone 
calls made by family physicians to people in isolation, in line 
with the guidelines. These additional control measures started 
on 16 March 2020; their purpose was to assess individuals' 
condition, increase compliance with the isolation rules, and 
reduce the circulation of the virus, reducing the number of new 
cases [7]. This study aims to evaluate the effectiveness of home 
isolation, and medical follow-up was done for a sample of 
patients recorded in the primary health care services in the Şişli 
Hamidiye Etfal Family Health Center in Istanbul city, Turkey. 
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Methods 
Study population and sample  
A retrospective and descriptive study designed to evaluate the 
isolated home COVID-19 confirmed, probable, or suspected 
cases in Istanbul city between March 16 and May 5, 2020. This 
study was conducted on patients registered in Şişli Hamidiye 
Etfal Family Health Center; is a public primary healthcare 
center located in the sisli city, the European side of Istanbul. It 
is a family health center with seven doctors and seven nurses, 
providing primary health care services to approximately 20,000 
people.  
 
Inclusion and exclusion criteria  
All confirmed, probable, or suspected cases of COVID-19, both 
gender and all ages who were isolated at home, under treatment 
and following up by the family physicians over the phone 
between 1st and 30th April 2020, and willing to participate are 
included in the study. Patients who were unwilling to 
participate and those with missing data are excluded from the 
study.  
 
The sampling technique  
The universal sampling technique was recruited to collect data 
from all (confirmed, probable, or suspicious COVID-19 
patients) who were already recorded at the Şişli Hamidiye Etfal 
Family Health Center, Istanbul, Turkey. Family physicians used 
the available data to contact patients directly via the phone 
during the regular follow-up to progress COVID-19 infection. 
 
Data collection tools  
Individuals isolated at home were followed up via phone calls. 
The respondents were asked to answer a total of 13 questions in 
four different parts and giving responses as either "Yes" or 
"No". The first section contained information about the 
participants' social and demographic characteristics, including 
citizenship number, age, and gender. The second section was 
about the participants' case types (confirmed, probable, or 
suspicious COVID-19 cases), nasopharyngeal PCR 
(Polymerase Chain Reaction) test results, computed 
tomography (CT) scan findings, treatment status, comorbidities, 
tobacco smoking, and the people with whom they live. In the 
third part, the focus was on the three main symptoms of 
COVID-19 (fever, cough, shortness of breath), length of the 
symptom, and whether the symptoms appeared in other family 
members or not. The fourth section contained information about 
compliance with specified quarantine rules, i.e., not leaving the 
house, not accepting visitors, being alone in a separate room to 
other members of the household, sufficiently ventilating the 
room, wearing a medical mask in all common areas of the 
house, cleaning the areas like WC/bathroom after each use, 
hand hygiene, separate use of household items such as plates, 
glasses, and towels. 
 
Statistical analysis  
The SPSS for Windows program was used for statistical 
analysis. Descriptive statistics of evaluation results are given as 
a number and percentage for categorical variables such as mean, 
standard deviation, and minimum, maximum for numerical 
variables. The differences between the rates of categorical 
variables in independent groups were tested with Chi-Square 
Analysis. The correlated parameters were also evaluated by 
regression analysis. Statistical alpha significance level was 
accepted as p <0.05. 
 
Results  
Characteristics of the participants 
Out of 1150 eligible women, 906 were included in the study 
(response rate 60.4%). The mean age was 29.59 (±4.74 years).  
Most of the respondents were high educated (75.2%), 
housewives (86.1%), nuclear family (96.1%), and low-income 
(≤4400 TL) families (53.9%). Most of the respondents neither 
having a history of psychiatric disease (95.9%) nor having a 
family member with a history of psychiatric disease (87.3 Out 
of 463 people who were followed up in isolation and defined as 
a confirmed, probable, or suspicious COVID-19 cases, 211 
(45.6%) of them were in contact with confirmed cases, 56 
(12.1%) were confirmed cases, and 196 (42.3%) were 
suspicious cases. The average age of the individuals was 35.38 
∓17.1 (0-86 years). More than half (249, 53.8%) of the 
followed-up patients were males, most diagnosed after the peak 
period (290, 63%), and the majority were living with their 
immediate families (396, 85.5%). About one-quarter (114, 
24.62%) of them reported at least one comorbidity and history 
of tobacco smoking (103, 22.2%) with an average of 
16.19∓12.3 cigarettes per day in a range of 1-65 cigarettes daily 
(Table 1). 
 
Table 1 Socio-demographic factors (n=463) 
Variables  Category  N (%) 
COVID-19 
cases 
Contact with confirmed 
cases 
211 (45.6) 
 Confirmed cases 56 (12.1) 
 Suspicious cases 196 (42.3) 
Gender  Male  249(53.8) 
 Female  214 (46.2) 
Time of 
diagnosis  
Before the peak 173 (37.0) 
 After the peak 290 (63.0) 
Living situation  Alone 22 (4.8) 
 With their immediate 
families 
396 (85.5) 
 With their extended 
families 
45 (9.7) 
Co-morbidities  No  349 (75.4) 
 Yes  114 (24.6) 
Yes (n=114) Having only one co-
morbidity 
82 (17.7) 
  Having two co-morbidities 26 (5.6) 





High Blood Pressure 
(Hypertension) 
41 (8.9) 
 Diabetic Disease  26 (5.6) 
 Heart disease 7 (1.5) 
 Lung disease  35 (7.6) 
 Others  43 (9.3) 
Tobacco 
smoking  
No  360 (77.8) 
 Yes  103 (22.2) 
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COVID-19 related symptoms and the associated factors  
Out of total patients, 79 (17.1%) were symptomatic. Most of 
them presented with cough (30.0%), shortness of breath 
(19.5%), weakness (11.1%), fever (9.5%), and sore throat 
(8.4%), respectively (Figure 1). Moreover, 18 (3.9%) of the 
patient who was followed up in isolation had a fever which 
lasted for an average of 4.17∓2.3 (1-7 days) days. Cough has 
lasted for an average of 8,43∓9,6 (1-36 days) in 57 (12.3%) 
patients. The long-lasting symptom was shortness of breath for 
an average of 20.53∓19.4 (3-60 days). 
Figure 1 Frequency distribution of symptoms 
 
Out of 310 (67.0%) of the followed patients underwent PCR 
test, and about one-fifth (67, 21.6%) confirmed positive results. 
Moreover, one-third(159, 34.3%) exposed to CT scan; however, 

















                                   
  
 
Figure 2 The flow chart of the included cases 
 
Table 2 presents the relationship between the PCR results, CT 
findings, and the main symptoms associated with COVID-19. 
The relationship between having a cough and a PCR positive 
test was significant (P= 0.003). About two-quarter 41 (61.2%) 
of the PCR positive individuals were symptomatic, for which 
the most common symptom was cough (19, 28.4)). Moreover, 
more than half (28, 54.9%) of the positive CT finding patients 
were symptomatic, for which the most common symptom was 
cough (22, 20.6%). 
Compliance with isolation rules 
During the lockdown period, most of the patients followed up in 
this study showed high compliance with the isolation rules. 
However, 21.2% of them left their house at least once, and 
1.9% received visitors. Two-thirds, 65.4% followed social 
distancing rules; however, 43.8%did not wear masks when 
being in public areas. More than ninety percent of the patients 
were paying attention to ventilation rooms, cleanness at 
individual and family levels (Table 3).  
     Table 4 presents the relationship between PCR results and 
compliance with the isolation rules. Chi-square test showed that 
a patient who is going out of the house is significantly 
associated with positive PCR (p <0.001). However, the patients 
who are staying alone in a separate room (P<0.001),  using a 
medical mask (p<0.001), cares about toilet/bathroom hygiene 
(P=0.006), and those who separate use of items such as plates, 
Glasses, and Towels (P=0.015).  
     Table 5 presents the descriptive of comorbidities, tobacco 
smoking, and medication used in relation to PCR results. Out of 
67 (%) PCR positive patients, 12 (27.0%) were hypertensive, 3 
(23.0%) chronic lung disease, 7 (%) diabetic patients and 2 () 
heart disease. When the co-morbidities were examined 
separately, there was a significant relationship between the 
hypertensive patients and the PCR positivity (p = 0.021). Out of 
67 (%) PCR positive patients, 9 (13.4%) were tobacco smokers. 
There was a significant relationship between smoking and PCR 
positivity (p = 0.024). Out of 463 patients followed in this 
study, 91 (19.7%) of them used medication. Most of them (67, 
73.6%) were PCR positive, while 24 (26.4%) were PCR 
negative but had positive CT findings. Hydroxychloroquine, 
Oseltamivir, and Favipiravir were used to treat 91,18, 5 
patients, respectively.  
 
Association of sociodemographic and clinical variables with 
the positive PCR and CT  
The median age of individuals with PCR positive was 38 years. 
More than half (40, 59.7%) were males, compared to 27 
(40.3%) were females. There was no significant relationship 
between PCR positivity and pandemic period, age, or gender (p 
= 0.149; p = 0.545; p = 0.285), respectively. Although older 
individuals had a higher rate of CT scan compatible with 
COVID-19, the relation between increased age and COVID-19 
compatible CT was found not to be statistically significant (p = 
0.053). Moreover, there was a significant relationship between 
CT scan positivity and tobacco smoking and diabetes (p = 
0.032; p = 0.016),  respectively. However, analysis found no 
significant relationship between CT scan positivity and gender, 
hypertension, heart disease, lung disease (p = 0.132; p = 0.214; 
p = 0.707; p = 0.093), respectively.  
 
Discussion  
In this study, more than half (59.7%) of patients with a positive 
PCR were males with a median age of 38 years, which is 
younger than that reported in the United States (48 years) by 
Stokes et al. [8] and that reported in China (49.6 years) by Yang 
et al. [9]. In our sample, the median age was younger than 
earlier studies because the PCR positive patients consisted of 
only those who were followed up during home-based self-
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Table 2 Association of PCR results and CT findings with main COVID-19 symptoms 
Symptoms Category  PCR +ve PCR -ve P Category  CT +ve CT -ve P-value 
  N(%) n(%)   n(%) n(%)  
Total observation  N=310 67 (21.6) 243(78.4)  N=158 51(32.3) 107(67.7)  
Fever Yes 6 (9.0) 10(4.1) 0.113 Yes 4(7.8) 7(6.5) 0.747 
 No 61(91.0) 233(95.9)  No 47(92.2) 100(93.5)  
Cough Yes 19(28.4) 32(13.2) 0.003 Yes 22(20.6) 13(25.5) 0.485 
 No 48(71.6) 211(86.8)  No 85(79.4) 38(74.5)  
Shortness of breath Yes 6(9.0) 30(12.3) 0.443 Yes 7(13.7) 21(19.6) 0.364 
 No 61(91.0) 213(87.7)  No 44(86.3) 86(80.4)  
PCR: Polymerase Chain Reaction; CT: computed tomography 
 
Table 3 Compliance with isolation rules(n=463) 




Leaving home at least once 98 (21.2) 365(78.8) 
Accepted visitors 9 (1.9%) 454(98.1) 
Obeying to the social distancing rules 303(65.4) 160 (34.6) 
Ventilating the room at the 
recommended frequency 
452(97.6) 11 (2.4) 
Wearing masks in the common areas 260(56.2) 203 (43.8) 
Cleaning the common areas such as 
the bathroom after each use 
419(90.5) 44 (9.5) 
Paying attention to the separate use of 
household items such as plates, 
glasses, and towels 
427(92.2) 36 (7.8) 
 
Moreover, the scientific literature explains the increase in PCR 
positivity in men due to more concentrations of angiotensin-
converting enzyme 2 (ACE2) in their blood than in women. The 
abundance of  ACE2 allows a higher level of the coronavirus to 
be transmitted to healthy cells, making them more susceptible to 
COVID-19. The prevalence rate of tobacco smoking is higher 
among men than women, which increases their risk of lung 
disease [10], while women have a high level of immunity due to 
an increase in the X chromosome [11]. Previous studies found 
that women are more committed to protection standards from 
the coronavirus than men [12,13,14].  
     Furthermore, men are more commonly employed in jobs 
outside the home and most likely subjected to less social 
distancing rules. At the time of this study, out of 310 patients 
who underwent to PCR test, 67 (21.6%) returned a positive 
result. Our findings rated higher than the global percent (7.0%) 
[15] and the official Turkish rate (6.3%) [16]. This difference is 
because the individuals who have been followed up all 
considered to be likely causes. 
     Likewise to our findings, several studies  [8, 9,17,18 ] 
reported that cardiovascular disease (hypertension and coronary 
heart disease), diabetes, and chronic lung diseases are the most 
common comorbidities related to COVID-19 PCR positive 
cases. Stokes et al. [8], in their report, found that cardiovascular 
disease, diabetes, and chronic lung diseases rated 32%, 32%, 
and 18%, respectively, among United States PCR positive 
cases. Yang et al. [9], in their meta-analysis, reported that 
hypertension (21.1%), diabetes (9.7%), and cardiovascular 
diseases (8.4%) are in the top list of PCR positive related 




diabetes, and coronary heart disease diagnosed in 30%, 19%, 
and 8%, of the PCR positive cases, respectively. 
     In the bivariate analysis, we found a statistically significant 
relationship between hypertension and PCR positive patients. 
Wang et al. [18] found that the coronavirus worsens with high 
blood pressure. More than 26.0% of the total population have 
hypertension [19] and common among adults [20]. Moreover, 
Lippi et al. [21] have stressed that the mechanism of action of 
the enzyme ACE2 explains its role in explaining the 
relationship between high blood pressure and infection with 
COVID-19. Among the 67 PCR positive studied patients, 9 
(13.4%) had a positive history of tobacco smoking; however, 
the rate was lower than the national rate of tobacco smoking 
(29.3%) reported in 2018 [22]. Zhang et al. [19, 23] reported a 
rate of 7.0% tobacco smokers among the COVID-19 patients, 
which is lower than the rate of adult smoking prevalence 
(27.7%) in China [24]. Moreover, in our study, we found a 
significant relationship between non-tobacco smoking and PCR 
positivity (p = 0.024). Unlike our results, Zhao et al. [25] and 
Zhang et al. [23] found a statistically significant relationship 
between tobacco smoking and the severity of COVID-19 
disease among patients. Different findings were reported by 
Vardavas et al. [26], who calculated a relative risk indicating a 
non-significant relationship between tobacco smoking and the 
severity of COVID-19. However, Simons et al. [27] concluded 
that there was significant uncertainty in the relationship 
between tobacco smoking and COVID-19 results. The 
symptoms of COVID-19 occurred in most cases approximately 
4 to 5 days after exposure. Similarly, Li et al. [28] reported a 
mean incubation period of 5.2 days in China. Asymptomatic 
infections frequency is unknown, but several studies in various 
settings show that they are common.  
     Mizumoto et al. [29] estimated the asymptomatic proportion 
among the Japanese people was 17.9%. Our findings showed 
that 26 (38.8%) of the PCR-positive individuals were 
asymptomatic. However, the most common symptom was 
cough. Similarly to previous studies, the symptomatic cases 
presented with fever (43.0%), cough (50.0%) and/or shortness 
of breath (29.0%), upper respiratory symptoms (20.0%), 
headache (34.0%), myalgia (36.0%), diarrhea (19.0%), nausea-
vomiting (12.0%) and loss of sense of smell or taste (10.0%) are 
also common [4, 30].  
     The American Association of Infectious Diseases (IDSA) 
recommends testing nasopharyngeal specimens instead of the 
oropharyngeal specimen (or saliva) due to lower sensitivity to 
oropharyngeal specimens and lack data on the accuracy of 
saliva specimens [31].  
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Table 4 Relationship between PCR results and compliance with isolation rules (n=310) 
Variables  Category  PCR + PCR - P-value 
  n(%) n(%)  
Total observation  N=310 67 (21.6) 243(78.4)  
Going Out of the house Yes 4(6.0) 69(28.4) 0.000 
 No 63(94.0) 174(71.6)  
Visitor Acceptance Yes 3(4.5) 4(1.6) 0.167 
 No 64(95.5) 239(98.4)  
Staying alone in a separate room Yes 60(89.6) 148(60.9) 0.000 
 No 7(10.4) 95(39.1)  
The Ventilation of the Room Yes 66(98.5) 235(96.7) 0.437 
 No 1(1.5) 8(3.3)  
Using Medical Mask Yes 56(83.6) 119(49.0) 0.000 
 No 11(16.4) 124(51.0)  
Cleaning WC/bathroom Yes 66(98.5) 211(86.8) 0.006 
 No 1(1.5) 32(13.2)  
Hand hygiene Yes 66(98.5) 236(97.1) 0.526 
 No 1(1.5) 7(2.9)  
Separate use of items such as plates, Glasses, and Towels Yes 67(100) 223(91.8) 0.015 
 No 0 20 (8.2)  
Table 5 Descriptive of co-morbidities, tobacco smoking, and medication used in relation to PCR results 
*Individuals with negative PCR results but positive CT. 
 
Fang et al. [34] reported that among 51 patients hospitalized in 
China with fever or acute respiratory symptoms and ultimately 
a positive PCR test, the initial PCR test was negative in 15 
patients (29.0%), and they were subsequently diagnosed only 
after repeated tests.  
     Similarly, Lee et al. [35] found that the first nasopharyngeal 
test was 11% negative among 70 Singaporean patients. Long et 
al. [36] examined the rates of conversion from negative to 
positive NP SARS-CoV-2 RT-PCR. The authors found that 
3.5% of the 626 patients retested who underwent repeated 
nasopharyngeal PCR tests within seven days of the first 
negative test in the USA were eventually found to be positive. 
The test's sensitivity will most likely depend on the type and 
quality of the sample, the duration of the disease during the test, 
and the specific assay. However, chest CT abnormalities were 
also identified before symptoms developed and even before 
PCR positivity was detected [37].  
     Chest CT scan is a vital component in the diagnostic 
algorithm for patients suspected of COVID-19 infection. 




after the onset of symptoms and is therefore not a reliable, 
independent tool to rule out COVID-19 infection [38]. 
     In the context of the typical clinical presentation and 
exposure to other people with COVID-19, the CT scan features 
of viral pneumonia may be strong indicators for COVID-19 
infection despite negative PCR results. In these cases, even 
though literature recommends repeated stick testing and patient 
isolation [38]. In Turkey, these cases were treated as positive 
cases of COVID-19 [39]. In this study, 24 patients with CT 
findings and symptom positivity were treated for COVID-19 
even though their PCR results were negative.    
     Kenny and his colleagues [40] concluded that respiratory 
function decreased significantly among smokers and diabetics 
patients for ten years or more, with a clear association with a 
significant reduction in quality of life and impaired ability to 
exercise. Also, there was a suppression of the immune system 
by diabetes [41] and a negative effect of smoking on the lungs 
[42]. In this study, the positivity of CT findings was found to be 
associated with smoking and diabetes. Considering the results 
mentioned above, we believe that the evaluation of symptoms, 
PCR, and CT scan together in COVID-19 diagnosis will 
Variables  Categories PCR non PCR Total 









Co-morbidities Hypertension  12(17.9) 20(8.2) 9(5.9) 41  
Chronic Lung Disease 3(4.5) 26(10.7) 6(3.9) 35  
Diabetes 7(10.4) 13(5.3) 6(3.9) 26  
Heart Disease 2(3.0) 4(1.6) 1(0.7) 7  
Others 5(7.5) 31(12.7) 7(4.6) 43 
Healthy individuals 
 
38(56.7) 149(61.3) 124(81.0) 311 
Tobacco Smoker  9(13.4) 65(26.7) 29(19.0) 103 
Non-smokers  58(86.6) 178(73.3) 124(81.0) 360 
Used medication  67(100) 24(9.9)* 0 91 
Non used medication  0 219(90.1) 153(100) 372 
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generally facilitate the diagnosis and should be evaluated 
simultaneously, especially in individuals with cough. 
Patients suspected or confirmed with COVID-19 (including 
those waiting for test results) should stay at home and isolate 
themselves from other people and animals at home. It is 
suggested that the patient should be placed alone in a well-
ventilated room, leaving a distance of at least 1 meter (e.g., 
sleeping in a separate bed) if a separate room is not possible.  
     It is also recommended to limit the patient's movement at 
home and to minimize the shared space. If those who share a 
living space with these people need to be in the same room, the 
World Health Organization (WHO) recommends these people 
wear a medical mask [43]. It also recommends not allowing 
visitors, applying hand hygiene after any contact, and using 
disposable paper towels to dry hands. If these are not available, 
using clean towels and changing them frequently, using special 
food utensils for the patient, and cleaning the surfaces where the 
patient touches the room, for example, bathrooms and toilets, 
with hypochlorite containing 0.1% sodium are also 
recommended. In order to be released from home isolation, a 
negative PCR result must be obtained at least twice from 
patients, with the samples being taken 24 hours apart [44].  
     This study complaint of some limitations. Since only phone 
calls are used to follow-up of isolation patients, the data are 
based on the verbal statements of the patients. This situation 
creates a limitation in terms of the accuracy of the information. 
 
Policy implication 
Given the instructions and the guide prepared in Turkey 
[6,7,16], the recommendations of the World Health 
Organization and the Center for Disease Control, the health 
status of the isolated individuals were followed up. All data in 
this study were recorded during the first call to patients. Some 
of the home isolation patients were not compliant with the 
isolation rules at the time of the first call because they have 
difficulty adapting to the various aspects of quarantine. 
However, the subsequent calls showed that patients' compliance 
had increased in almost all instances. It was also observed that 
individuals with PCR positivity had higher levels of compliance 
with the isolation rules. This study indicated two reasons for the 
increased compliance with the isolation rules found in the 
subsequent phone interviews; the patients might become more 
are aware of the seriousness of the disease and better understand 
the severity of the disease due to their treatment; and the role of 
the regular follow-up of the patients by phone.  
 
Conclusion  
This study found that men are more commonly infected with 
COVID-19 than women. Patients with a positive history of 
chronic diseases, especially hypertension, are more likely to 
contract the disease. Moreover, it was determined that the 
combination of PCR tests, symptoms, and CT scans would 
increase the likelihood of a correct diagnosis. Although it 
increases the workload of family physicians and public health 
specialists, the continued observation and follow-up of the 
quarantined COVID-19 patients increase their compliance with 
the isolation regulations. Moreover, to reduce the workload of 
family doctors and public health professionals, it is 
recommended that initial contact with patients in home isolation 
be made by a trained health professional. 
Abbreviation  
COVID-19: Coronavirus; PCR: Polymerase Chain Reaction; CT: 
Computed Tomography; SARS-CoV: Severe Acute  Respiratory  
Syndrome; WHO: The World Health Organization;  CDC: Centers for 
Disease Control and Prevention; ACE: Angiotensin-Converting 
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